Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials ; volume:18 ; number:1 ; day:21 ; month:3 ; year:2020 ; pages:1-10 ; date:12.2020
World journal of surgical oncology ; 18, Heft 1 (21.3.2020), 1-10, 12.2020
- Creator
-
Kumar, Tarun
Pai, Esha
Singh, Rajesh
Francis, Neville J.
Pandey, Manoj
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-020-01830-x
- URN
-
urn:nbn:de:101:1-2020061321314764225991
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kumar, Tarun
- Pai, Esha
- Singh, Rajesh
- Francis, Neville J.
- Pandey, Manoj
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer
Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer
Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer